Full Text View
Tabular View
Study Results
Related Studies
Study of NTx®-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients (REGENESIS-LED)
This study has been terminated.
( Slow Enrollment )
Study NCT00938314   Information provided by Stem Cell Therapeutics Corp.

First Received on July 9, 2009.   Last Updated on November 24, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Stroke
Additional conditions recognized in this trial
Cerebral Infarction
More general conditions related to this trial
Brain Diseases
Brain Infarction
Brain Ischemia
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Nervous System Diseases
Vascular Diseases
Interventions listed in this trial
Saline Placebo
Additional drug interventions recognized in this trial
Chorionic Gonadotropin
Epoetin Alfa
More general drug interventions related to this trial
Hematinics
Hematologic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
Stem Cell Therapeutics Corp.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services